Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership2,611,345 shares
Latest Disclosed Value $ 9,165,821
Citadel Advisors Llc ownership in IOVA / Iovance Biotherapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 2,611,345 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $9,165,821 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,143,091 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of -16.92% during the quarter. The current value of the position is $11,045,989 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (IOVA) in the form of stock options. The firm currently holds call options representing 759,000 of underlying shares valued at $2,664,090 USD and put options representing 492,200 of underlying shares valued at $1,727,622 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IOVA / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,611,345 -531,746 -16.92 9,166 6.82 0.0015
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,143,091 -677,273 -17.73 8,581 3.50 0.0013
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,820,364 -293,224 -7.13 8,290 17.17 0.0013
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 4,113,588 2,380,785 137.40 7,075 22.62 0.0012
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,732,803 639,199 58.45 5,770 -28.70 0.0011
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,093,604 69,768 6.81 8,093 -15.82 0.0014
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,023,836 780,578 320.88 9,614 392.97 0.0019
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 243,258 -867,739 -78.10 1,951 -88.16 0.0004
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,110,997 824,963 288.41 16,465 608.13 0.0032
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 286,034 -103,101 -26.49 2,325 31.36 0.0005
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 389,135 -945,312 -70.84 1,771 -81.16 0.0004
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,334,447 -2,137,584 -61.57 9,395 -55.72 0.0019
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,472,031 1,177,989 51.35 21,214 44.73 0.0047
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,294,042 1,862,210 431.23 14,659 254.31 0.0034
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 431,832 -2,089,992 -82.88 4,137 -85.14 0.0009
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,521,824 2,386,618 1,765.17 27,841 1,136.83 0.0071
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 135,206 -110,752 -45.03 2,251 -52.06 0.0005
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 245,958 -1,107,605 -81.83 4,695 -85.93 0.0010
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 1,353,563 -1,024,101 -43.07 33,379 -46.05 0.0069
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,377,664 1,621,945 214.62 61,867 158.58 0.0138
2021-05-21 2021-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 755,719 -570,173 -43.00 23,926 -61.11 0.0059
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 755,719 -570,173 23,926 0.0059
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,325,892 34,494 2.67 61,521 44.71 0.0160
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,291,398 -549,748 -29.86 42,513 -15.88 0.0121
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 1,841,146 1,432,331 350.36 50,539 312.97 0.0180
2020-05-15 2020-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 408,815 103,031 33.69 12,238 44.59 0.0055
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 305,784 220,465 258.40 8,464 445.36 0.0037
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 85,319 -217,528 -71.83 1,552 -79.10 0.0007
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 302,847 -1,636,021 -84.38 7,426 -59.73 0.0034
2019-05-15 2019-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 1,938,868 -2,488,645 -56.21 18,439 -52.94 0.0092
2019-02-14 2018-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 4,427,513 1,126,352 34.12 39,183 5.51 0.0215
2018-11-13 2018-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 3,301,161 2,841,526 618.21 37,138 531.17 0.0166
2018-08-14 2018-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS Cmn 462260100 459,635 264,160 135.14 5,884 78.09 0.0029
2018-08-10 2018-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 459,635 264,160 5,884
2018-05-14 2018-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS Cmn 462260100 195,475 163,531 511.93 3,304 1,190.63 0.0018
2018-05-11 2018-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 195,475 163,531 3,304
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 31,944 -23,380 -42.26 256 -40.33 0.0002
2017-11-09 2017-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn 462260100 55,324 1,762 3.29 429 7.52 0.0003
2017-05-12 2017-03-31 13F LION BIOTECHNOLOGIES Cmn 53619R102 53,562 12,806 31.42 399 40.99 0.0004
2017-02-10 2016-12-31 13F LION BIOTECHNOLOGIES Cmn 53619R102 40,756 -5,984 -12.80 283 -26.49 0.0003
2017-01-31 2016-09-30 13F/A-1 LION BIOTECHNOLOGIES Cmn 53619R102 46,740 27,086 137.81 385 142.14 0.0004
2016-11-10 2016-09-30 13F LION BIOTECHNOLOGIES Cmn 53619R102 46,740 385
2017-01-31 2016-06-30 13F/A-1 LION BIOTECHNOLOGIES Cmn 53619R102 19,654 7,021 55.58 159 148.44 0.0002
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES Cmn 53619R102 19,654 159
2017-01-31 2016-03-31 13F/A-1 LION BIOTECHNOLOGIES Cmn 53619R102 12,633 -21,678 -63.18 64 -75.85 0.0001
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES Cmn 53619R102 12,633 64
2017-01-31 2015-12-31 13F/A-1 LION BIOTECHNOLOGIES Cmn 53619R102 34,311 34,311 -46.20 265 -54.70 0.0003
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES Cmn 53619R102 34,311 265
2015-11-16 2015-09-30 13F LION BIOTECHNOLOGIES Cmn 53619R102 0 -63,781 -100.00 0 -100.00
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES Cmn 53619R102 63,781 63,781 585 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 759,000 24.92 2,664 60.68 n/a n/a n/a
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 607,600 4.20 1,659 31.07 n/a n/a n/a
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 583,100 35.79 1,265 71.41 n/a n/a n/a
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 429,400 42.61 739 -26.35 n/a n/a n/a
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 301,100 -30.45 1,003 -68.72 n/a n/a n/a
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 432,900 32.14 3,203 4.13 n/a n/a n/a
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 327,600 5.10 3,076 23.09 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 311,700 -48.83 2,500 -72.32 n/a n/a n/a
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 609,200 79.02 9,028 226.39 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 340,300 -3.57 2,767 72.34 n/a n/a n/a
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 352,900 20.24 1,606 -22.31 n/a n/a n/a
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 293,500 -9.53 2,066 4.24 n/a n/a n/a
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 324,400 88.39 1,982 80.18 n/a n/a n/a
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 172,200 -16.41 1,100 -44.25 n/a n/a n/a
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 206,000 -25.44 1,973 -35.31 n/a n/a n/a
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 276,300 -36.79 3,050 -58.09 n/a n/a n/a
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 437,100 79.07 7,278 56.18 n/a n/a n/a
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 244,100 7.44 4,660 -16.83 n/a n/a n/a
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 227,200 14.69 5,603 8.69 n/a n/a n/a
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 198,100 45.77 5,155 19.80 n/a n/a n/a
2021-05-21 2021-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Call 135,900 -41.95 4,303 -60.38 n/a n/a n/a
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 135,900 4,303 n/a n/a n/a
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 234,100 134.80 10,862 230.96 n/a n/a n/a
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 99,700 -42.37 3,282 -30.89 n/a n/a n/a
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 173,000 43.33 4,749 31.44 n/a n/a n/a
2020-05-15 2020-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 120,700 -45.09 3,613 -40.61 n/a n/a n/a
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 219,800 -45.77 6,084 -17.52 n/a n/a n/a
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 405,300 56.73 7,376 16.32 n/a n/a n/a
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 258,600 6,341 n/a n/a n/a
2019-05-15 2019-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 18,400 -64.68 163 -72.18 n/a n/a n/a
2018-11-13 2018-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 52,100 86.07 586 63.69 n/a n/a n/a
2018-08-14 2018-06-30 13F/A IOVANCE BIOTHERAPEUTICS Cmn Call 28,000 -1.06 358 -25.10 n/a n/a n/a
2018-08-10 2018-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Call 28,000 358 n/a n/a n/a
2018-05-14 2018-03-31 13F/A IOVANCE BIOTHERAPEUTICS Cmn Call 28,300 152.68 478 431.11 n/a n/a n/a
2018-05-11 2018-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 28,300 478 n/a n/a n/a
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Call 11,200 90 n/a n/a n/a
2017-05-12 2017-03-31 13F LION BIOTECHNOLOGIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F LION BIOTECHNOLOGIES Cmn Call 10,000 -23.66 70 -35.19 n/a n/a n/a
2017-01-31 2016-09-30 13F/A LION BIOTECHNOLOGIES Cmn Call 13,100 108 n/a n/a n/a
2016-11-10 2016-09-30 13F LION BIOTECHNOLOGIES Cmn Call 13,100 108 n/a n/a n/a
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-03-31 13F/A LION BIOTECHNOLOGIES Cmn Call 40,300 196.32 205 95.24 n/a n/a n/a
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES Cmn Call 40,300 205 n/a n/a n/a
2017-01-31 2015-12-31 13F/A LION BIOTECHNOLOGIES Cmn Call 13,600 105 n/a n/a n/a
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES Cmn Call 13,600 105 n/a n/a n/a
2015-11-16 2015-09-30 13F LION BIOTECHNOLOGIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES Cmn Call 800 7 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 492,200 -25.22 1,728 -3.84 n/a n/a n/a
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 658,200 1.70 1,797 27.92 n/a n/a n/a
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 647,200 12.13 1,404 41.53 n/a n/a n/a
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 577,200 -14.49 993 -55.85 n/a n/a n/a
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 675,000 -32.29 2,248 -69.54 n/a n/a n/a
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 996,900 51.80 7,377 19.64 n/a n/a n/a
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 656,700 54.96 6,166 81.46 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 423,800 12.71 3,399 -39.02 n/a n/a n/a
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 376,000 -2.94 5,572 76.95 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 387,400 -27.49 3,150 29.54 n/a n/a n/a
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 534,300 195.85 2,431 91.27 n/a n/a n/a
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 180,600 61.83 1,271 86.64 n/a n/a n/a
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 111,600 -14.68 682 -18.44 n/a n/a n/a
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 130,800 84.23 836 22.79 n/a n/a n/a
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 71,000 -30.73 680 -39.93 n/a n/a n/a
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 102,500 -48.90 1,132 -66.11 n/a n/a n/a
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 200,600 18.70 3,340 3.53 n/a n/a n/a
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 169,000 -9.29 3,226 -29.78 n/a n/a n/a
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 186,300 3.50 4,594 -1.92 n/a n/a n/a
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 180,000 5.76 4,684 -13.08 n/a n/a n/a
2021-05-21 2021-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Put 170,200 31.53 5,389 -10.24 n/a n/a n/a
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 170,200 5,389 n/a n/a n/a
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 129,400 215.61 6,004 344.74 n/a n/a n/a
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 41,000 -60.16 1,350 -52.21 n/a n/a n/a
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 102,900 430.41 2,825 386.23 n/a n/a n/a
2020-05-15 2020-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 19,400 -8.92 581 -1.53 n/a n/a n/a
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 21,300 -2.74 590 47.87 n/a n/a n/a
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 21,900 -20.65 399 -41.06 n/a n/a n/a
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 27,600 677 n/a n/a n/a
2019-05-15 2019-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 18,100 -19.91 160 -37.01 n/a n/a n/a
2018-11-13 2018-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 22,600 44.87 254 27.00 n/a n/a n/a
2018-08-14 2018-06-30 13F/A IOVANCE BIOTHERAPEUTICS Cmn Put 15,600 39.29 200 5.82 n/a n/a n/a
2018-08-10 2018-06-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 15,600 200 n/a n/a n/a
2018-05-14 2018-03-31 13F/A IOVANCE BIOTHERAPEUTICS Cmn Put 11,200 189 n/a n/a n/a
2018-05-11 2018-03-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 11,200 189 n/a n/a n/a
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-09 2017-09-30 13F IOVANCE BIOTHERAPEUTICS Cmn Put 10,800 84 n/a n/a n/a
2016-11-10 2016-09-30 13F LION BIOTECHNOLOGIES Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-06-30 13F/A LION BIOTECHNOLOGIES Cmn Put 10,200 83 n/a n/a n/a
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES Cmn Put 10,200 83 n/a n/a n/a
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A LION BIOTECHNOLOGIES Cmn Put 1,300 10 n/a n/a n/a
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES Cmn Put 1,300 10 n/a n/a n/a
2015-11-16 2015-09-30 13F LION BIOTECHNOLOGIES Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES Cmn Put 4,900 45 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.